4 The patency superiority of paclitaxel DES over
PTA (74.8% vs 26.5%) and BMS (83.4% vs 64.1%) was sustained in a 2-year follow-up report of the same study.212
PTFE-covered self-expanding stents have been used to
treat long-segment lesions within the SFA for patients
with claudication, although their superiority to B